Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children

P. Montuschi, C. Mondino, P. Koch, G. Baviera (Rome, Italy)

Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session: Anti-inflammatory therapy for childhood asthma
Session type: Electronic Poster Discussion
Number: 2707
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi, C. Mondino, P. Koch, G. Baviera (Rome, Italy). Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children. Eur Respir J 2007; 30: Suppl. 51, 2707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Measurement of exhaled nitric oxide can not reliably predict exacerbations in school-aged asthmatic children using inhaled corticosteroids
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009


Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004

Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Source: Eur Respir J 2005; 25: 289-294
Year: 2005



The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007


Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003

The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007

Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Increased exhaled nitric oxide in nonatopic asthma
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003


The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001